LP206560-7

Disopyramide+Nordisopyramide

Active

Description

This assay measures both disopyramide and its major metabolite, nordisopyramide, and does not distinguish between them. The parent drug, disopyramide (trade names Norpace and Rythmodan) is an antiarrhythmic medication used in the treatment of ventricular tachycardia It is a sodium channel blocker and therefore classified as a Class 1a anti-arrhythmic agent. Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the contractility. Disopyramide also has an anticholinergic effect on the heart which accounts for many adverse side effects. Disopyramide is available in both oral and intravenous forms, and has a low degree of toxicity. [Wikipedia: Disopyramide] Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia: Disopyramide

Basic Part Properties

Part Name

Disopyramide+Nordisopyramide

Part Display Name

Disopyramide+Nordisopyramide

Part Type

Component (Describes the core component or analyte measured)

Created On

2016-01-04

Construct for LOINC Short Name

Disopyramide+Nordisopyramide

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP206560-7

Language Variants Get Info

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.